Antitumour response and nephrotoxicity following intraperitoneal administration of a slow release formulation of cisplatin to rats bearing cancers restricted to the peritoneal cavity.
Los
G
G
Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam.
Kop
W
W
Deurloo
M J
MJ
D000818:Animals; D002945:Cisplatin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use* / Q000633:toxicity; D003404:Creatinine / Q000097:blood; D003692:Delayed-Action Preparations; D004343:Drug Implants; D005782:Gels; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D008297:Male; D010534:Peritoneal Neoplasms / Q000188:drug therapy*; D051381:Rats; D011919:Rats, Inbred Strains
D003692:Delayed-Action Preparations; D004343:Drug Implants; D005782:Gels; D003404:Creatinine; D002945:Cisplatin